Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP

L. Angus, S. Moleirinho, L. Herron, A. Sinha, X. Zhang, M. Niestrata, K. Dholakia, Michael B. Prystowsky, K. F. Harvey, P. A. Reynolds, F. J. Gunn-Moore

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The Drosophila melanogaster protein Expanded acts in the Hippo signaling pathway to control organ size. Previously, willin/FRMD6 has been proposed as the human orthologue of Expanded. Willin lacks C-terminal sequences that are present in Expanded and, to date, little is known about the functional role of willin in mammalian cells. When willin is expressed in D. melanogaster epithelial tissues, it has the same subcellular localization as Expanded, but cannot rescue growth defects associated with expanded deficiency. However, we show that ectopic willin expression causes an increase in phosphorylation of the core Hippo signaling pathway components MST1/2, LATS1 and YAP, an effect that can be antagonized by ezrin. In MCF10A cells, loss of willin expression displays epithelial-to-mesenchymal transition features and willin overexpression antagonizes YAP activity via the N-terminal FERM domain of willin. Therefore, in mammalian cells willin influences Hippo signaling activity by activating the core Hippo pathway kinase cassette.

Original languageEnglish (US)
Pages (from-to)238-250
Number of pages13
JournalOncogene
Volume31
Issue number2
DOIs
StatePublished - Jan 12 2012

Fingerprint

Mammals
Phosphotransferases
Organ Size
Contact Inhibition
Drosophila Proteins
Warts
Epithelial-Mesenchymal Transition
Growth
Drosophila melanogaster
Epithelium
Phosphorylation
Cell Proliferation
Apoptosis
Neoplasms

Keywords

  • Expanded
  • ezrin
  • Hippo pathway
  • merlin
  • Willin/FRMD6

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Angus, L., Moleirinho, S., Herron, L., Sinha, A., Zhang, X., Niestrata, M., ... Gunn-Moore, F. J. (2012). Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. Oncogene, 31(2), 238-250. https://doi.org/10.1038/onc.2011.224

Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. / Angus, L.; Moleirinho, S.; Herron, L.; Sinha, A.; Zhang, X.; Niestrata, M.; Dholakia, K.; Prystowsky, Michael B.; Harvey, K. F.; Reynolds, P. A.; Gunn-Moore, F. J.

In: Oncogene, Vol. 31, No. 2, 12.01.2012, p. 238-250.

Research output: Contribution to journalArticle

Angus, L, Moleirinho, S, Herron, L, Sinha, A, Zhang, X, Niestrata, M, Dholakia, K, Prystowsky, MB, Harvey, KF, Reynolds, PA & Gunn-Moore, FJ 2012, 'Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP', Oncogene, vol. 31, no. 2, pp. 238-250. https://doi.org/10.1038/onc.2011.224
Angus, L. ; Moleirinho, S. ; Herron, L. ; Sinha, A. ; Zhang, X. ; Niestrata, M. ; Dholakia, K. ; Prystowsky, Michael B. ; Harvey, K. F. ; Reynolds, P. A. ; Gunn-Moore, F. J. / Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. In: Oncogene. 2012 ; Vol. 31, No. 2. pp. 238-250.
@article{2db19e65d2924a10a22c3810af4d69cb,
title = "Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP",
abstract = "The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The Drosophila melanogaster protein Expanded acts in the Hippo signaling pathway to control organ size. Previously, willin/FRMD6 has been proposed as the human orthologue of Expanded. Willin lacks C-terminal sequences that are present in Expanded and, to date, little is known about the functional role of willin in mammalian cells. When willin is expressed in D. melanogaster epithelial tissues, it has the same subcellular localization as Expanded, but cannot rescue growth defects associated with expanded deficiency. However, we show that ectopic willin expression causes an increase in phosphorylation of the core Hippo signaling pathway components MST1/2, LATS1 and YAP, an effect that can be antagonized by ezrin. In MCF10A cells, loss of willin expression displays epithelial-to-mesenchymal transition features and willin overexpression antagonizes YAP activity via the N-terminal FERM domain of willin. Therefore, in mammalian cells willin influences Hippo signaling activity by activating the core Hippo pathway kinase cassette.",
keywords = "Expanded, ezrin, Hippo pathway, merlin, Willin/FRMD6",
author = "L. Angus and S. Moleirinho and L. Herron and A. Sinha and X. Zhang and M. Niestrata and K. Dholakia and Prystowsky, {Michael B.} and Harvey, {K. F.} and Reynolds, {P. A.} and Gunn-Moore, {F. J.}",
year = "2012",
month = "1",
day = "12",
doi = "10.1038/onc.2011.224",
language = "English (US)",
volume = "31",
pages = "238--250",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP

AU - Angus, L.

AU - Moleirinho, S.

AU - Herron, L.

AU - Sinha, A.

AU - Zhang, X.

AU - Niestrata, M.

AU - Dholakia, K.

AU - Prystowsky, Michael B.

AU - Harvey, K. F.

AU - Reynolds, P. A.

AU - Gunn-Moore, F. J.

PY - 2012/1/12

Y1 - 2012/1/12

N2 - The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The Drosophila melanogaster protein Expanded acts in the Hippo signaling pathway to control organ size. Previously, willin/FRMD6 has been proposed as the human orthologue of Expanded. Willin lacks C-terminal sequences that are present in Expanded and, to date, little is known about the functional role of willin in mammalian cells. When willin is expressed in D. melanogaster epithelial tissues, it has the same subcellular localization as Expanded, but cannot rescue growth defects associated with expanded deficiency. However, we show that ectopic willin expression causes an increase in phosphorylation of the core Hippo signaling pathway components MST1/2, LATS1 and YAP, an effect that can be antagonized by ezrin. In MCF10A cells, loss of willin expression displays epithelial-to-mesenchymal transition features and willin overexpression antagonizes YAP activity via the N-terminal FERM domain of willin. Therefore, in mammalian cells willin influences Hippo signaling activity by activating the core Hippo pathway kinase cassette.

AB - The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The Drosophila melanogaster protein Expanded acts in the Hippo signaling pathway to control organ size. Previously, willin/FRMD6 has been proposed as the human orthologue of Expanded. Willin lacks C-terminal sequences that are present in Expanded and, to date, little is known about the functional role of willin in mammalian cells. When willin is expressed in D. melanogaster epithelial tissues, it has the same subcellular localization as Expanded, but cannot rescue growth defects associated with expanded deficiency. However, we show that ectopic willin expression causes an increase in phosphorylation of the core Hippo signaling pathway components MST1/2, LATS1 and YAP, an effect that can be antagonized by ezrin. In MCF10A cells, loss of willin expression displays epithelial-to-mesenchymal transition features and willin overexpression antagonizes YAP activity via the N-terminal FERM domain of willin. Therefore, in mammalian cells willin influences Hippo signaling activity by activating the core Hippo pathway kinase cassette.

KW - Expanded

KW - ezrin

KW - Hippo pathway

KW - merlin

KW - Willin/FRMD6

UR - http://www.scopus.com/inward/record.url?scp=84855784320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855784320&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.224

DO - 10.1038/onc.2011.224

M3 - Article

VL - 31

SP - 238

EP - 250

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 2

ER -